Federation Bio Revenue and Competitors
Estimated Revenue & Valuation
- Federation Bio's estimated annual revenue is currently $5.2M per year.
- Federation Bio's estimated revenue per employee is $77,500
- Federation Bio's total funding is $50M.
Employee Data
- Federation Bio has 67 Employees.
- Federation Bio grew their employee count by 24% last year.
Federation Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Head CMC Operations | Reveal Email/Phone |
2 | Senior Bioinformatics Scientist | Reveal Email/Phone |
Federation Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Federation Bio?
Federation Bio is pioneering new platforms that target diseases in which the human microbiome can play a curative role. The company’s microbial approach leverages naturally occurring bacteria along with a diverse community of supportive bacteria to drive engraftment and durable therapeutic responses. This approach has potential in a diverse set of human conditions ranging from metabolic disorders and cholestatic diseases to cancer and autoimmune conditions. Federation Bio’s lead program is in secondary hyperoxaluria, a serious renal condition that affects more than 200,000 Americans and for which there are currently no approved therapies. Additional information can be found at www.federation.bio
keywords:N/A$50M
Total Funding
67
Number of Employees
$5.2M
Revenue (est)
24%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Federation Bio News
Prior to Federation Bio, she spent over a decade at 23andMe where, as Vice President of Business Development, she was instrumental in...
Federation Bio — a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role — announced that it has raised $50 million in a Series A round of funding Federation Bio — a microbial therapeutics company targeting diseases in which the human microbiom ...
Federation Bio, a South San Francisco, CA-based microbial therapeutics company targeting diseases in which the human microbiome can play a curative role, closed a $50m Series A financing. Horizons Ventures led the Series A financing, joined by existing investors Venrock and Altitude, and additi ...
SOUTH SAN FRANCISCO, Calif., Oct. 6, 2020 /PRNewswire/ -- Federation Bio, a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role, today announced that it has closed a $50 million Series A financing and expanded its leadership team. Federation ...
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.6M | 67 | 6% | $410.5M |
#2 | $15M | 67 | 2% | $1.4B |
#3 | $14.8M | 67 | 34% | N/A |
#4 | $8.7M | 67 | 5% | N/A |
#5 | $13.7M | 67 | 91% | N/A |
